Literature DB >> 22002224

Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization.

Mikyung Kim1, Zhen-Yu J Sun, Kasper D Rand, Xiaomeng Shi, Likai Song, Yuxing Cheng, Amr F Fahmy, Shreoshi Majumdar, Gilad Ofek, Yongping Yang, Peter D Kwong, Jia-Huai Wang, John R Engen, Gerhard Wagner, Ellis L Reinherz.   

Abstract

Broadly neutralizing antibodies such as 2F5 are directed against the membrane-proximal external region (MPER) of HIV-1 GP41 and recognize well-defined linear core sequences. These epitopes can be engrafted onto protein scaffolds to serve as immunogens with high structural fidelity. Although antibodies that bind to this core GP41 epitope can be elicited, they lack neutralizing activity. To understand this paradox, we used biophysical methods to investigate the binding of human 2F5 to the MPER in a membrane environment, where it resides in vivo. Recognition is stepwise, through a paratope more extensive than core binding site contacts alone, and dynamic rearrangement through an apparent scoop-like movement of heavy chain complementarity-determining region 3 (CDRH3) is essential for MPER extraction from the viral membrane. Core-epitope recognition on the virus requires the induction of conformational changes in both the MPER and the paratope. Hence, target neutralization through this lipid-embedded viral segment places stringent requirements on the plasticity of the antibody combining site.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22002224      PMCID: PMC3253551          DOI: 10.1038/nsmb.2154

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  58 in total

1.  Identification and characterization of EX1 kinetics in H/D exchange mass spectrometry by peak width analysis.

Authors:  David D Weis; Thomas E Wales; John R Engen; Matthew Hotchko; Lynn F Ten Eyck
Journal:  J Am Soc Mass Spectrom       Date:  2006-07-27       Impact factor: 3.109

2.  The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies.

Authors:  Damian Houde; Steven A Berkowitz; John R Engen
Journal:  J Pharm Sci       Date:  2010-12-29       Impact factor: 3.534

3.  Relationship between antibody 2F5 neutralization of HIV-1 and hydrophobicity of its heavy chain third complementarity-determining region.

Authors:  Gilad Ofek; Krisha McKee; Yongping Yang; Zhi-Yong Yang; Jeff Skinner; F Javier Guenaga; Richard Wyatt; Michael B Zwick; Gary J Nabel; John R Mascola; Peter D Kwong
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

4.  Molecular characterization of five neutralizing anti-HIV type 1 antibodies: identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5.

Authors:  R Kunert; F Rüker; H Katinger
Journal:  AIDS Res Hum Retroviruses       Date:  1998-09-01       Impact factor: 2.205

5.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

Review 6.  Interaction of antibodies with ErbB receptor extracellular regions.

Authors:  Karl R Schmitz; Kathryn M Ferguson
Journal:  Exp Cell Res       Date:  2008-10-22       Impact factor: 3.905

7.  Interactions between lipids and human anti-HIV antibody 4E10 can be reduced without ablating neutralizing activity.

Authors:  Hengyu Xu; Likai Song; Mikyung Kim; Margaret A Holmes; Zane Kraft; George Sellhorn; Ellis L Reinherz; Leonidas Stamatatos; Roland K Strong
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

8.  Crystallographic definition of the epitope promiscuity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5: vaccine design implications.

Authors:  Steve Bryson; Jean-Philippe Julien; Rosemary C Hynes; Emil F Pai
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

9.  Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens.

Authors:  Xiaodong Xiao; Weizao Chen; Yang Feng; Zhongyu Zhu; Ponraj Prabakaran; Yanping Wang; Mei-Yun Zhang; Nancy S Longo; Dimiter S Dimitrov
Journal:  Biochem Biophys Res Commun       Date:  2009-09-11       Impact factor: 3.575

10.  Structural basis of semaphorin-plexin signalling.

Authors:  Bert J C Janssen; Ross A Robinson; Francesc Pérez-Brangulí; Christian H Bell; Kevin J Mitchell; Christian Siebold; E Yvonne Jones
Journal:  Nature       Date:  2010-09-26       Impact factor: 49.962

View more
  55 in total

1.  Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6.

Authors:  Gilad Ofek; Brett Zirkle; Yongping Yang; Zhongyu Zhu; Krisha McKee; Baoshan Zhang; Gwo-Yu Chuang; Ivelin S Georgiev; Sijy O'Dell; Nicole Doria-Rose; John R Mascola; Dimiter S Dimitrov; Peter D Kwong
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

2.  Thermodynamic analysis of the binding of 2F5 (Fab and immunoglobulin G forms) to its gp41 epitope reveals a strong influence of the immunoglobulin Fc region on affinity.

Authors:  Sara Crespillo; Salvador Casares; Pedro L Mateo; Francisco Conejero-Lara
Journal:  J Biol Chem       Date:  2013-12-03       Impact factor: 5.157

3.  The membrane proximal external regions of gp41 from HIV-1 strains HXB2 and JRFL have different sensitivities to alanine mutation.

Authors:  Hyun Ah Yi; Barbara Diaz-Rohrer; Priyanka Saminathan; Amy Jacobs
Journal:  Biochemistry       Date:  2015-02-19       Impact factor: 3.162

4.  Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design.

Authors:  Young D Kwon; Ivelin S Georgiev; Gilad Ofek; Baoshan Zhang; Mangaiarkarasi Asokan; Robert T Bailer; Amy Bao; William Caruso; Xuejun Chen; Misook Choe; Aliaksandr Druz; Sung-Youl Ko; Mark K Louder; Krisha McKee; Sijy O'Dell; Amarendra Pegu; Rebecca S Rudicell; Wei Shi; Keyun Wang; Yongping Yang; Mandy Alger; Michael F Bender; Kevin Carlton; Jonathan W Cooper; Julie Blinn; Joshua Eudailey; Krissey Lloyd; Robert Parks; S Munir Alam; Barton F Haynes; Neal N Padte; Jian Yu; David D Ho; Jinghe Huang; Mark Connors; Richard M Schwartz; John R Mascola; Peter D Kwong
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

5.  Replication in bioanalytical studies with HDX MS: aim as high as possible.

Authors:  Jamie A Moroco; John R Engen
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.681

6.  Rational design of membrane proximal external region lipopeptides containing chemical modifications for HIV-1 vaccination.

Authors:  Vincent J Venditto; Douglas S Watson; Michael Motion; David Montefiori; Francis C Szoka
Journal:  Clin Vaccine Immunol       Date:  2012-10-31

Review 7.  Antibody-based candidate therapeutics against HIV-1: implications for virus eradication and vaccine design.

Authors:  Weizao Chen; Tianlei Ying; Dimiter S Dimitrov
Journal:  Expert Opin Biol Ther       Date:  2013-01-07       Impact factor: 4.388

8.  Immunogenicity of membrane-bound HIV-1 gp41 membrane-proximal external region (MPER) segments is dominated by residue accessibility and modulated by stereochemistry.

Authors:  Mikyung Kim; Likai Song; James Moon; Zhen-Yu J Sun; Anna Bershteyn; Melissa Hanson; Derek Cain; Selasie Goka; Garnett Kelsoe; Gerhard Wagner; Darrell Irvine; Ellis L Reinherz
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

9.  Internal dynamics of the homotrimeric HIV-1 viral coat protein gp41 on multiple time scales.

Authors:  Nils-Alexander Lakomek; Joshua D Kaufman; Stephen J Stahl; John M Louis; Alexander Grishaev; Paul T Wingfield; Ad Bax
Journal:  Angew Chem Int Ed Engl       Date:  2013-02-28       Impact factor: 15.336

Review 10.  Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41.

Authors:  Hyun A Yi; Brian C Fochtman; Robert C Rizzo; Amy Jacobs
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.